
Cooper Companies (COO) Stock Forecast & Price Target
Cooper Companies (COO) Analyst Ratings
Bulls say
Cooper Companies is well-positioned for growth and profitability in the near future due to its strong market position as one of the largest eyecare companies in the US and its diverse portfolio of products in both the contact lens and medical device markets. The recent interest in selling its CooperSurgical business and using the proceeds for share repurchases could provide a boost to earnings in the coming years. While there are risks to consider, such as competition and currency headwinds, potential upside drivers, such as better than expected revenue and margin growth, could lead to strong performance for the company. Overall, I believe in the strong fundamentals of Cooper Companies and am optimistic about its future prospects.
Bears say
Cooper Companies is facing some concerns regarding the performance of its CooperSurgical segment, with its F2H26 sales projected to grow only in the high-single digits. Additionally, the company's revenue and EPS estimates were lowered for FY26 and FY27, and there are conflicting opinions on the potential success of its new product, MyDay MiSight. These factors, coupled with ongoing industry challenges in the APAC region, lead to a negative outlook on the company's stock.
This aggregate rating is based on analysts' research of Cooper Companies and is not a guaranteed prediction by Public.com or investment advice.
Cooper Companies (COO) Analyst Forecast & Price Prediction
Start investing in Cooper Companies (COO)
Order type
Buy in
Order amount
Est. shares
0 shares